Author:
Orendáš Peter,Ahlers Ivan,Bojková Bianka,Kassayová Monika,Kubatka Peter,Kajo Karol,Péč Martin,Ahlersová Eva,Friedmanová Lenka
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Plant Science,Genetics,Molecular Biology,Animal Science and Zoology,Biochemistry,Ecology, Evolution, Behavior and Systematics
Reference20 articles.
1. Abou-Issa H.M., Alshafie G.A., Seibert K., Koki A.T., Masferrer J.L. & Harris R.E. 2001. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res. 21(5): 3425–3432.
2. Agrawal A. & Fentiman I.S. 2008. NSAIDs and breast cancer: a possible prevention and treatment strategy. Int. J. Clin. Pract. 62(3): 444–449. DOI: 10.1111/j.1742-1241.2007.01668.x.
3. Harris R.E. 2007. Cyclooxygenase-2 /COX-2/and the inflammogenesis of cancer, Chapter 4, pp. 93–126. In: Harris R.E. (ed.), Inflammation in the Pathogenesis of Chronic Diseases, Series: Subcellular Biochemistry, Vol. 42, Springer, New York, 323 pp. ISBN: 978-1-4020-5687-1
4. Harris R.E., Beebe-Donk J. & Alshafie G.A. 2006. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6: 27. DOI: 10.1186/1471-2407-6-27
5. Harris R.E., Beebe-Donk J. & Schuller H.M. 2002. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol. Rep. 9(4): 693–695.